STRS Ohio’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-552,637
Closed -$54.9M 2203
2019
Q3
$54.9M Buy
552,637
+9,820
+2% +$933K 0.24% 111
2019
Q2
$50.2M Sell
542,817
-115,543
-18% -$11M 0.22% 115
2019
Q1
$62.1M Sell
658,360
-151,228
-19% -$13.2M 0.28% 87
2018
Q4
$51.9M Buy
809,588
+40,906
+5% +$3.02M 0.26% 106
2018
Q3
$68.8M Buy
768,682
+63,719
+9% +$5.63M 0.3% 79
2018
Q2
$56M Buy
704,963
+194,995
+38% +$16.2M 0.24% 117
2018
Q1
$45.5M Sell
509,968
-358,451
-41% -$34.4M 0.2% 148
2017
Q4
$90.6M Sell
868,419
-40,167
-4% -$4.53M 0.39% 54
2017
Q3
$132M Buy
908,586
+18,110
+2% +$2.47M 0.57% 30
2017
Q2
$116M Sell
890,476
-68,628
-7% -$8.41M 0.52% 34
2017
Q1
$119M Sell
959,104
-21,979
-2% -$2.63M 0.52% 36
2016
Q4
$114M Sell
981,083
-31,673
-3% -$3.53M 0.5% 39
2016
Q3
$106M Sell
1,012,756
-46,977
-4% -$5.08M 0.47% 42
2016
Q2
$105M Sell
1,059,733
-13,732
-1% -$1.42M 0.46% 47
2016
Q1
$107M Buy
1,073,465
+65,492
+6% +$6.74M 0.48% 45
2015
Q4
$121M Buy
1,007,973
+119
+0% +$13.8K 0.54% 39
2015
Q3
$109M Buy
1,007,854
+66,752
+7% +$8.28M 0.52% 37
2015
Q2
$109M Sell
941,102
-5,865
-0.6% -$671K 0.48% 42
2015
Q1
$109M Buy
946,967
+128,276
+16% +$15.3M 0.48% 41
2014
Q4
$91.6M Sell
818,691
-40,386
-5% -$4.26M 0.4% 60
2014
Q3
$81.4M Hold
859,077
0.36% 66
2014
Q2
$73.8M Buy
859,077
+24,163
+3% +$1.84M 0.33% 84
2014
Q1
$58.3M Buy
834,914
+8,000
+1% +$634K 0.26% 115
2013
Q4
$69.9M Sell
826,914
-43,556
-5% -$3.45M 0.31% 85
2013
Q3
$67M Buy
870,470
+255,410
+42% +$17.9M 0.3% 90
2013
Q2
$36M Buy
+615,060
New +$37M 0.15% 192

Other funds holding CELG

STRS Ohio's CELG Position: Q4 2019 in Review

STRS Ohio sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 552,637 shares — an estimated $54.9M sold.

STRS Ohio first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $132M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • STRS Ohio reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • STRS Ohio sold 552,637 Celgene Corp shares in Q4 2019, an estimated $54.9M.
  • STRS Ohio first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • STRS Ohio's Celgene Corp position peaked at $132M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on STRS Ohio's 13F filing for Q4 2019, filed 24 Jan 2020.